[Inhibitor of calmodulin and calmodulin dependent enzyme].
Hidaka
H
H
Department of Pharmacology, Nagoya University School of Medicine, Japan.
Naito
Y
Y
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D020013:Calcium Signaling / Q000502:physiology*; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000037:antagonists & inhibitors; D002147:Calmodulin / Q000037:antagonists & inhibitors* / Q000502:physiology*; D054677:Cyclic Nucleotide Phosphodiesterases, Type 1; D006801:Humans; D009219:Myosin-Light-Chain Kinase / Q000037:antagonists & inhibitors; D009281:Naphthalenes / Q000494:pharmacology; D009282:Naphthalenesulfonates / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases; D013449:Sulfonamides / Q000494:pharmacology; D014748:Vinca Alkaloids / Q000494:pharmacology
D002147:Calmodulin; D009281:Naphthalenes; D009282:Naphthalenesulfonates; D010640:Phenothiazines; D010726:Phosphodiesterase Inhibitors; D013449:Sulfonamides; D014748:Vinca Alkaloids; C013983:vinpocetine; C063302:KN 62; C017967:W 7; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D009219:Myosin-Light-Chain Kinase; D010727:Phosphoric Diester Hydrolases; D054677:Cyclic Nucleotide Phosphodiesterases, Type 1